Explore more publications!

STEM Review Turks & Caicos: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Review Turks & Caicos.

Press releases published on November 13, 2025

Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission
Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del tercer trimestre de 2025
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented
Calian Announces First VENTURES Defence Partnership with TACTIQL
Aduro Clean Technologies to be Featured on “Earth with John Holden”
VisionWave Enters LOI to Acquire BladeRanger Subsidiary, Expanding AI-Driven Drone Capabilities for Security, Infrastructure, and Emergency Response
AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data
AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes
Draganfly Secures Second Major Order from Fortune 50 Telecommunications Company to Expand NDAA-Compliant Heavy Lift Drone Fleet
Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference
Rumble Cloud Partners with the Cleveland Browns
Bitdeer Announces Pricing of US$400.0 Million Convertible Senior Notes Offering
Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Youxin Technology Ltd Provides Update on Strengthened Balance Sheet
Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update
Odysight.ai Reports Financial Results for The Nine Months Ended September 30, 2025 and Provides Business Update
AlphaTON Capital and SingularityNET Join Forces to Accelerate Telegram’s Cocoon AI – Growing the Ethical, Decentralized AI Ecosystem
La MHRA approuve la demande d’essai clinique de BetaGlue Therapeutics pour YntraDose™ dans le traitement du cancer du pancréas localement avancé non résécable (uLA-PDAC)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions